Adicet Bio, Inc.
ACET · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$117,122 | -$142,658 | -$69,790 | -$61,999 |
| Dep. & Amort. | $6,468 | $6,098 | $2,575 | $1,538 |
| Deferred Tax | $0 | $0 | $0 | $1,231 |
| Stock-Based Comp. | $22,233 | $20,259 | $17,126 | $12,511 |
| Change in WC | -$5,525 | $252 | $2,744 | -$6,057 |
| Other Non-Cash | $1,568 | $22,332 | $2,580 | $1,724 |
| Operating Cash Flow | -$92,378 | -$93,717 | -$44,765 | -$51,052 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1,118 | -$4,464 | -$16,782 | -$13,046 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$129,124 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $11,000 | $0 | $0 | $10,250 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$119,242 | -$4,464 | -$16,782 | -$2,796 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $110,918 | $386 | $43,360 | $238,129 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $389 | -$150 | -$1,851 | $4,556 |
| Financing Cash Flow | $111,307 | $236 | $41,509 | $242,685 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$100,313 | -$97,945 | -$20,038 | $188,837 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $159,711 | $257,656 | $277,694 | $88,857 |
| End Cash | $59,398 | $159,711 | $257,656 | $277,694 |
| Free Cash Flow | -$93,496 | -$98,181 | -$61,547 | -$64,098 |